VC  Open Prairie Ventures

http://www.openprairie.com





     Office Locations:

400 East Jefferson
Effingham, IL 62410
Phone: 217-347-1000
Fax: 217-347-1001

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early
  • Growth
  • Seed


 

Industries:

  • Communications & Networking
  • Food & Agriculture
  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Open Prairie Ventures is an early-stage venture capital firm investing in promising IT, wireless communication, and life science technology companies. Open Prairie Ventures was founded in 1999 as a venture capital firm focused on early-stage Midwest-based technolgy companies. The first investment fund, Open Prairie Ventures I, L.P. (OPV I), was formerly licensed by the Small Business Administration as a Small Business Investment Company (SBIC). In 2006, JIm Schultz, Michael Peck, and Dennis Beard recapitalized the SBA's Limited Partner interest in OPV I through a buyout of the SBA position. OPV I completed fifteen investments with four successful exits, including the 2007 IPO of TomoTherapy (NASDAQ: TOMO) and has four active portfolio investments remaining. The firm's second fund, Open Prairie Ventures II, provides early-stage venture capital to companies focused on the convergence of ag-tech and life science technologies. The fund deploys less than $15 million of syndicated capital to develop, commercialize, and exit.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Dennis Beard Chief Financial Officer & General Partner
    Jason Wrone Vice President of Investments
    Jim Schultz Founder & Managing Partner
    Michael Peck General Partner
    Pat Morand President

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      09/07/2017


      NewLeaf Symbiotics


      MO


      $30,000,000


      Series C


      07/14/2017


      Collectly


      CA


      undisclosed


      


      07/10/2017


      NewLeaf Symbiotics


      MO


      $24,000,000


      Series C


     

    Portfolio companies include:


      Cernium
        web link


      Collectly
        web link


      Compact Particle Acceleration
        web link


      Epiworks
        web link


      InfoBlox
        web link


      ISSI
        web link


      KCBioMediX
        web link


      NewLeaf Symbiotics
        web link


      Novita Therapeutics
        web link


      Vestaron
        web link


     

    Recent News: